Does OBINUTUZUMAB Cause Atrial fibrillation? 548 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 548 reports of Atrial fibrillation have been filed in association with OBINUTUZUMAB (Gazyva). This represents 3.9% of all adverse event reports for OBINUTUZUMAB.
548
Reports of Atrial fibrillation with OBINUTUZUMAB
3.9%
of all OBINUTUZUMAB reports
36
Deaths
141
Hospitalizations
How Dangerous Is Atrial fibrillation From OBINUTUZUMAB?
Of the 548 reports, 36 (6.6%) resulted in death, 141 (25.7%) required hospitalization, and 23 (4.2%) were considered life-threatening.
Is Atrial fibrillation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 548 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Atrial fibrillation?
APIXABAN (5,690)
IBRUTINIB (3,671)
LENALIDOMIDE (2,704)
RITUXIMAB (2,100)
SACUBITRIL\VALSARTAN (2,062)
RIVAROXABAN (2,027)
ADALIMUMAB (1,709)
METOPROLOL (1,462)
DEXAMETHASONE (1,461)
METHOTREXATE (1,411)
Which OBINUTUZUMAB Alternatives Have Lower Atrial fibrillation Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE